Product
Supplier
Encyclopedia
Inquiry
Vildagliptin buy - large image1
Vildagliptin buy - image1

Vildagliptin

4 Inquiries

Unit Price: Get Latest Price
CAS No.:

274901-16-5

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

5KG;1KG

Price valid (until):

2024-08-08

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.

    Basic Info
    Product Name:

    Vildagliptin

    Other Name:

    2-Pyrrolidinecarbonitrile,1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-,(2S)-;2-Pyrrolidinecarbonitrile,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-,(2S)-;(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile;Vildagliptin;LAF 237;NVP-LAF 237;Galvus;Equa;DSP 7238;(S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile;(2S)-1-[2-[(3-Hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile;Xiliarx;Jalra;565453-38-5

    CAS No.:

    274901-16-5

    Molecular Formula:

    C17H25N3O2

    InChIKeys:

    InChIKey=SYOKIDBDQMKNDQ-XWTIBIIYSA-N

    Molecular Weight:

    303.39900

    Exact Mass:

    303.40

    ATC Code:

    A10BH02|A10BD08|A - Alimentary tract and metabolism

    HScode:

    2933990090

    Characteristics
    PSA:

    76.36000

    XLogP3:

    1.50308

    Appearance:

    white crystalline powder

    Density:

    1.27 g/cm3

    Melting Point:

    148-150 °C @ Solvent: Ethyl acetate, Isopropanol

    Boiling Point:

    531.3ºC at 760 mmHg

    Flash Point:

    275.1ºC

    Hazard Identification

    Classification of the substance or mixture

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 4

    GHS label elements, including precautionary statements

    Pictogram(s) No symbol.
    Signal word

    No signal word

    Hazard statement(s)

    H413 May cause long lasting harmful effects to aquatic life

    Precautionary statement(s)
    Prevention

    P273 Avoid release to the environment.

    Response

    none

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

    Location:

    2F Building 10, Zhuhai International Health Port, 628 Airport West Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, China 519090

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2012

    Certifications:

    CERTIFICATE OF REGISTRATION

    NewRoute Pharmaceutical Technology Co., Ltd

    NewRoute Pharma  located in Zhuhai, Guangdon Province, is an innovation-oriented enterprise who engages in R&D, production and sales of API, intermediates, formulations and impurity standards.

    Since its establishment in 2012 , the company has maintained a leading momentum in the field of new drug development . Specialized in new drug technology development and achievement transfer , our company is capable of providing other enterprises with various new drug R&D , production and supporting services , which is the reason for many pharmaceutical enterprises to establish strategic cooperation with us .

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Vildagliptin

    5 MT Nov 25, 2025
    India

    Vildagliptin

    100 KG Feb 13, 2026
    Tunisia

    Vildagliptin

    80 KG Dec 19, 2023
    India

    VILDAGLIPTIN

    100 KG Jul 22, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.